Cargando…

Phage Display of the Serpin Alpha-1 Proteinase Inhibitor Randomized at Consecutive Residues in the Reactive Centre Loop and Biopanned with or without Thrombin

In spite of the power of phage display technology to identify variant proteins with novel properties in large libraries, it has only been previously applied to one member of the serpin superfamily. Here we describe phage display of human alpha-1 proteinase inhibitor (API) in a T7 bacteriophage syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Scott, Benjamin M., Matochko, Wadim L., Gierczak, Richard F., Bhakta, Varsha, Derda, Ratmir, Sheffield, William P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888415/
https://www.ncbi.nlm.nih.gov/pubmed/24427287
http://dx.doi.org/10.1371/journal.pone.0084491
_version_ 1782299055246802944
author Scott, Benjamin M.
Matochko, Wadim L.
Gierczak, Richard F.
Bhakta, Varsha
Derda, Ratmir
Sheffield, William P.
author_facet Scott, Benjamin M.
Matochko, Wadim L.
Gierczak, Richard F.
Bhakta, Varsha
Derda, Ratmir
Sheffield, William P.
author_sort Scott, Benjamin M.
collection PubMed
description In spite of the power of phage display technology to identify variant proteins with novel properties in large libraries, it has only been previously applied to one member of the serpin superfamily. Here we describe phage display of human alpha-1 proteinase inhibitor (API) in a T7 bacteriophage system. API M358R fused to the C-terminus of T7 capsid protein 10B was directly shown to form denaturation-resistant complexes with thrombin by electrophoresis and immunoblotting following exposure of intact phages to thrombin. We therefore developed a biopanning protocol in which thrombin-reactive phages were selected using biotinylated anti-thrombin antibodies and streptavidin-coated magnetic beads. A library consisting of displayed API randomized at residues 357 and 358 (P2–P1) yielded predominantly Pro-Arg at these positions after five rounds of thrombin selection; in contrast the same degree of mock selection yielded only non-functional variants. A more diverse library of API M358R randomized at residues 352–356 (P7–P3) was also probed, yielding numerous variants fitting a loose consensus of DLTVS as judged by sequencing of the inserts of plaque-purified phages. The thrombin-selected sequences were transferred en masse into bacterial expression plasmids, and lysates from individual colonies were screening for API-thrombin complexing. The most active candidates from this sixth round of screening contained DITMA and AAFVS at P7–P3 and inhibited thrombin 2.1-fold more rapidly than API M358R with no change in reaction stoichiometry. Deep sequencing using the Ion Torrent platform confirmed that over 800 sequences were significantly enriched in the thrombin-panned versus naïve phage display library, including some detected using the combined phage display/bacterial lysate screening approach. Our results show that API joins Plasminogen Activator Inhibitor-1 (PAI-1) as a serpin amenable to phage display and suggest the utility of this approach for the selection of “designer serpins” with novel reactivity and/or specificity.
format Online
Article
Text
id pubmed-3888415
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38884152014-01-14 Phage Display of the Serpin Alpha-1 Proteinase Inhibitor Randomized at Consecutive Residues in the Reactive Centre Loop and Biopanned with or without Thrombin Scott, Benjamin M. Matochko, Wadim L. Gierczak, Richard F. Bhakta, Varsha Derda, Ratmir Sheffield, William P. PLoS One Research Article In spite of the power of phage display technology to identify variant proteins with novel properties in large libraries, it has only been previously applied to one member of the serpin superfamily. Here we describe phage display of human alpha-1 proteinase inhibitor (API) in a T7 bacteriophage system. API M358R fused to the C-terminus of T7 capsid protein 10B was directly shown to form denaturation-resistant complexes with thrombin by electrophoresis and immunoblotting following exposure of intact phages to thrombin. We therefore developed a biopanning protocol in which thrombin-reactive phages were selected using biotinylated anti-thrombin antibodies and streptavidin-coated magnetic beads. A library consisting of displayed API randomized at residues 357 and 358 (P2–P1) yielded predominantly Pro-Arg at these positions after five rounds of thrombin selection; in contrast the same degree of mock selection yielded only non-functional variants. A more diverse library of API M358R randomized at residues 352–356 (P7–P3) was also probed, yielding numerous variants fitting a loose consensus of DLTVS as judged by sequencing of the inserts of plaque-purified phages. The thrombin-selected sequences were transferred en masse into bacterial expression plasmids, and lysates from individual colonies were screening for API-thrombin complexing. The most active candidates from this sixth round of screening contained DITMA and AAFVS at P7–P3 and inhibited thrombin 2.1-fold more rapidly than API M358R with no change in reaction stoichiometry. Deep sequencing using the Ion Torrent platform confirmed that over 800 sequences were significantly enriched in the thrombin-panned versus naïve phage display library, including some detected using the combined phage display/bacterial lysate screening approach. Our results show that API joins Plasminogen Activator Inhibitor-1 (PAI-1) as a serpin amenable to phage display and suggest the utility of this approach for the selection of “designer serpins” with novel reactivity and/or specificity. Public Library of Science 2014-01-10 /pmc/articles/PMC3888415/ /pubmed/24427287 http://dx.doi.org/10.1371/journal.pone.0084491 Text en © 2014 Scott et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Scott, Benjamin M.
Matochko, Wadim L.
Gierczak, Richard F.
Bhakta, Varsha
Derda, Ratmir
Sheffield, William P.
Phage Display of the Serpin Alpha-1 Proteinase Inhibitor Randomized at Consecutive Residues in the Reactive Centre Loop and Biopanned with or without Thrombin
title Phage Display of the Serpin Alpha-1 Proteinase Inhibitor Randomized at Consecutive Residues in the Reactive Centre Loop and Biopanned with or without Thrombin
title_full Phage Display of the Serpin Alpha-1 Proteinase Inhibitor Randomized at Consecutive Residues in the Reactive Centre Loop and Biopanned with or without Thrombin
title_fullStr Phage Display of the Serpin Alpha-1 Proteinase Inhibitor Randomized at Consecutive Residues in the Reactive Centre Loop and Biopanned with or without Thrombin
title_full_unstemmed Phage Display of the Serpin Alpha-1 Proteinase Inhibitor Randomized at Consecutive Residues in the Reactive Centre Loop and Biopanned with or without Thrombin
title_short Phage Display of the Serpin Alpha-1 Proteinase Inhibitor Randomized at Consecutive Residues in the Reactive Centre Loop and Biopanned with or without Thrombin
title_sort phage display of the serpin alpha-1 proteinase inhibitor randomized at consecutive residues in the reactive centre loop and biopanned with or without thrombin
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888415/
https://www.ncbi.nlm.nih.gov/pubmed/24427287
http://dx.doi.org/10.1371/journal.pone.0084491
work_keys_str_mv AT scottbenjaminm phagedisplayoftheserpinalpha1proteinaseinhibitorrandomizedatconsecutiveresiduesinthereactivecentreloopandbiopannedwithorwithoutthrombin
AT matochkowadiml phagedisplayoftheserpinalpha1proteinaseinhibitorrandomizedatconsecutiveresiduesinthereactivecentreloopandbiopannedwithorwithoutthrombin
AT gierczakrichardf phagedisplayoftheserpinalpha1proteinaseinhibitorrandomizedatconsecutiveresiduesinthereactivecentreloopandbiopannedwithorwithoutthrombin
AT bhaktavarsha phagedisplayoftheserpinalpha1proteinaseinhibitorrandomizedatconsecutiveresiduesinthereactivecentreloopandbiopannedwithorwithoutthrombin
AT derdaratmir phagedisplayoftheserpinalpha1proteinaseinhibitorrandomizedatconsecutiveresiduesinthereactivecentreloopandbiopannedwithorwithoutthrombin
AT sheffieldwilliamp phagedisplayoftheserpinalpha1proteinaseinhibitorrandomizedatconsecutiveresiduesinthereactivecentreloopandbiopannedwithorwithoutthrombin